Interview: “Someone had to do it”, says SA TB activist on Time 100 list

At the age of 19 Phumeza Tisile contracted multidrug-resistant tuberculosis. For four years she battled the disease, losing her hearing in the process. At one stage, a doctor told her to visit a priest and prepare her soul for death. Recently, Tisile (now 33) made it on to TIME magazine’s 2023 TIME100 Next list, as one of 100 emerging leaders round the world who are “shaping the future and defining the next generation of leadership”. Sue Segar chatted to Tisile about her remarkable journey.

Read More

In-depth: What new WHO TB numbers mean for SA

An estimated 54 000 people died of tuberculosis in South Africa in 2022 and around 280 000 fell ill with the disease, according to just-released figures from the World Health Organization. Catherine Tomlinson unpacks the figures and what they mean for the country’s TB response.

Read More

Analysis: How does SA measure up against new TB recommendations?

A new report from the Lancet Commission on Tuberculosis (TB) titled ‘Scientific advances and the end of tuberculosis’ makes several recommendations for how governments should go about fighting the deadly, but curable, disease. Spotlight editor Marcus Low puts the Spotlight on how South Africa’s TB programme is measuring up against the recommendations.

Read More

Face to face: Prof Muki Shey on his journey from Cameroon to doing cutting-edge TB research

On 9 March, Professor Muki Shey received a silver award from the South African Medical Research Council for his “outstanding contribution to health research”. Shey is spearheading research into TB in healthcare workers from around Cape Town, scanning for those who over at least five years of high exposure to the disease at hospitals or clinics have never been infected. Biénne Huisman spoke to him about his journey from the North West of Cameroon to a lab at UCT and the value of ploughing back to help develop the next generation.

Read More

Women in Health: Francesca Conradie – from HIV to groundbreaking TB research

Dr Francesca Conradie knew she wanted to be a doctor when she was eight years old. Now, 50 years later, she is a pioneer in the field of tuberculosis (TB) and led a landmark trial that changed how drug-resistant TB is treated. Aisha Abdool Karim spoke to her about the reasons behind her switch from HIV research to TB, her initial surprise at the remarkable NiX trial results, and the man who has shaped her life – her father.

Read More